<?xml version="1.0" encoding="UTF-8"?>
<ref id="b18-1030717">
 <label>18.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kennedy</surname>
    <given-names>GA</given-names>
   </name>
   <name>
    <surname>Varelias</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Vuckovic</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Addition of interleukin 6 inhibition with tocilizumab to standard graft versus host disease prophylaxis after allogeneic stem cell transplantation: a phase 1/2 trial</article-title>. 
  <source>Lancet Oncol</source>. 
  <year>2014</year>;
  <volume>15</volume>(
  <issue>13</issue>):
  <fpage>1451</fpage>â€“
  <lpage>1459</lpage>.
  <pub-id pub-id-type="pmid">25456364</pub-id>
 </mixed-citation>
</ref>
